Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Evolution of HER2-targeted therapies: The role of antibody drug conjugates

Date

03 May 2019

Session

Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options

Presenters

Fabrice André

Authors

F. André

Author affiliations

  • Breast Cancer Unit, Medical Oncology Department, Gustave Roussy - Cancer Campus, 94805 - Villejuif/FR
More

Resources

Resources from the same session

Welcome & introduction

Presenter: Fabrice André

Session: Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options

Resources:

Presentation

Q&A with speaker panel

Presenter: Hope Rugo

Session: Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options

Resources:

Presentation

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings